title: Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma.
authors.affiliation: Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
authors.forename: Fumi
authors.initials: F
authors.lastname: Nakamura
authors.affiliation: Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Nakamura
authors.affiliation: Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
authors.forename: Masako
authors.initials: M
authors.lastname: Ikemura
authors.affiliation: Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
authors.forename: Masashi
authors.initials: M
authors.lastname: Fukayama
authors.affiliation: Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. kurokawa-tky@umin.ac.jp.
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002999:Clone Cells / Q000473:pathology; D018450:Disease Progression; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy* / Q000473:pathology; D009296:Nasal Cavity / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000473:pathology* / Q000532:radiotherapy; D009669:Nose Neoplasms / Q000473:pathology* / Q000532:radiotherapy; D010954:Plasmacytoma / Q000473:pathology* / Q000532:radiotherapy; D000069283:Rituximab / Q000009:adverse effects / Q000627:therapeutic use*; D012859:Sjogren's Syndrome / Q000150:complications
chemical_list: D000970:Antineoplastic Agents; D000069283:Rituximab